19:50 EDT Kazia Therapeutics (KZIA) trading halted, news pending
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KZIA:
- Kazia Therapeutics Announces ADS Ratio Change to Maintain Nasdaq Compliance
- Kazia Therapeutics Sells Cantrixil IP Rights to Vivesto for $1 Million
- Kazia Therapeutics sells IP, trademarks rights to Cantrixil for $1M
- Kazia Therapeutics Advances Cancer Drug Development with Strategic Moves and Promising Trial Results
- Kazia Therapeutics: Buy Rating Driven by Dual Potential in GBM and Parkinson’s Disease